You just read:

Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Oct 21, 2019, 07:58 ET